Kalvista Pharmaceuticals Inc (KALV)
Cost of Revenue
$3.98M
Quarterly · Period ending: · USD
KALV Cost of Revenue
Latest reported$3.98Mperiod ending
Latest reported$3.98Mperiod ending
KALV Quarterly Cost of Revenue ($0.00 → $3.98M)
Quarterly cost of revenue
High-resolution chart · PNG
KALV cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 3,976,000 | |
| 3,445,000 | |
| 1,232,000 | |
| 590,000 | |
| 15,891,000 | |
| 0 | |
| 0 | |
| 0 | |
| 25,248,000 | |
| 207,000 | |
| 19,089,000 | |
| 19,307,000 | |
| 23,951,000 | |
| 20,063,000 | |
| 18,077,000 | |
| 18,186,000 | |
| 19,213,000 | |
| 0 | |
| 0 | |
| 0 | |
| 11,877,000 | |
| 0 | |
| 0 | |
| 0 | |
| 9,485,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |